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specification occurs (Hatakeyama et al., 2001; Livesey
and Cepko, 2001), the molecular mechanisms that con-
trol which embryonic cells become specified as the de-
finitive retinal progenitors in the eye field remain
largely undefined.
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An accepted hypothesis of how the eye field forms isWashington, District of Columbia 20037
that signals from surrounding anterior structures region-3 Regulation of Cell Growth Laboratory
alize the anterior neural plate (Perron and Harris, 1999).National Cancer Institute-Frederick
The presumptive eye field then expresses several tran-Frederick, Maryland 21702
scription factors that initiate the retina developmental
program, e.g., rx1 (Mathers et al., 1997), pax6 (Chow et
al., 1999), and six3 (Loosli et al., 1999). However, cellular
movements during gastrulation and neurulation, di-Summary
rected in part by eye field transcription factors, also
are critical (Chuang and Raymond, 2001; Kenyon et al.,The definitive retinal progenitors of the eye field are
2001), and the signaling factors involved in these earlyspecified by transcription factors that both promote a
steps of eye field formation have not been identified.retinal fate and control cell movements that are critical
Several fibroblast growth factor (FGF) family membersfor eye field formation. However, the molecular signal-
have been implicated in affecting cell movements duringing pathways that regulate these movements are
gastrulation (Rossant et al., 1997; Wacker et al., 1998),largely undefined. We demonstrate that both the FGF
and the anterior expression patterns of some FGFs andand ephrin pathways impact eye field formation. Acti-
their receptors are consistent with a role in the morpho-vating the FGF pathway before gastrulation represses
genetic movements of eye field cells (Friesel and Dawid,cellular movements in the presumptive anterior neural
1991; Friesel and Brown, 1992; Song and Slack, 1994;plate and prevents cells from expressing a retinal fate,
Golub et al., 2000). Therefore, we investigated whether
independent of mesoderm induction or anterior-pos-
FGF signaling prior to gastrulation plays a role in de-
terior patterning. Inhibiting the FGF pathway promotes
termining which embryonic cells form the eye field. Us-
cell dispersal and significantly increases eye field con- ing a constitutively active FGF receptor, we demonstrate
tribution. ephrinB1 reverse signaling is required to pro- that enhanced FGF signaling prevents the normal retinal
mote cellular movements into the eye field, and can progenitors from populating the presumptive eye field,
rescue the FGF receptor-induced repression of retinal suggesting that low levels of FGF signaling are normally
fate. These results indicate that FGF modulation of required for cells to adopt a retinal fate. This was con-
ephrin signaling regulates the positioning of retinal firmed by demonstrating that reduced FGF signaling,
progenitor cells within the definitive eye field. accomplished by expression of a dominant-negative re-
ceptor, enhanced the number of cells that become reti-
nal progenitors. We further report that ephrinB1 signal-
Introduction ing during gastrulation is required for retinal progenitors
to move into the eye field, and that this movement can
Retinal development consists of a series of steps that be modified by activating the FGF pathway. Our results
progressively restrict the available cell fates. First, a demonstrate that FGF modulation of ephrin signaling is
subset of embryonic cells are prevented from express- important for establishing the bona fide retinal progeni-
ing a retinal fate by inherited maternal factors, whereas tors in the anterior neural plate.
others become biased toward retinal fates due to their
position within the neural inductive field of the animal
Resultshemisphere (Huang and Moody, 1993; Moore and Moody,
1999). As the CNS is regionalized, part of the anterior
Local Alterations in FGF Signaling Change Retinalneural plate is specified as the eye field. Potential retinal
Fates of Dorsal Animal Lineagesprogenitors need to be positioned within the eye field
Blocking FGF signaling beginning at late cleavageto receive the local environmental signals that will direct
stages does not affect the ability of retina-producingtheir ultimate fates (Saha and Grainger, 1992; Li et al.,
blastomeres to populate the eye field and the retina1997). Only after these steps are accomplished do the
(Moore and Moody, 1999). However, enhanced FGF sig-steps of eye organogenesis, cellular lamination, and
naling prevented these blastomeres from adopting aphenotype specification occur. Although there has been
retinal fate. Although overexpression of wild-type FGFgreat progress in understanding how retinal cell type
receptor 1 (FGFR1) in the major retinal progenitor
(D1.1.1; Figure 1A) did not alter that blastomere’s contri-
bution to the retina (all embryos contained retinal clones*Correspondence: anasam@gwumc.edu
and clone size was equivalent to that in GFP controls),4Present address: Department of Neurobiology and Anatomy, Uni-
versity of Utah, Salt Lake City, Utah 84132. overexpression of wild-type FGF receptor 2 (FGFR2)
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Figure 1. Activation of FGFR2 Signaling Prevents Cells from Adopting Retinal Fates
(A) Nomenclature of animal 32-cell blastomeres (Jacobson and Hirose, 1981). Dorsal is to the top.
(B) GFP-labeled D1.1.1 descendants in retina of control embryo. L, lens; di, diencephalon.
(C) Wild-type FGFR2-expressing D1.1.1 cells in retina.
(D) cFGFR2-expressing D1.1.1 cells are not in retina.
(E) Retinal volumes after expression of gfp or test mRNAs. Asterisk indicates significant difference (p  0.05) from controls.
(F) Anterior view showing -gal-injected D1.1.1 clone (red) in eye field (rx1, blue).
(G) In cFGFR2-injected embryo, rx1 expression (blue) is missing on the injected side (arrow).
(H) In XFD-injected embryo, rx1 expression (pink) is larger on the injected side (arrow).
reduced the numbers of D1.1.1 cells that populated the Activation of FGFR2 Signaling Represses
Eye Field Formationretina from 50% in controls to 12%–25% (Figures 1B and
1C). To amplify the FGF signal, we utilized constitutively We tested whether cFGFR affects the formation of the
eye field, which is the earliest specified retinal progenitoractive forms, cFGFR1 and cFGFR2, containing point
mutations that result in ligand-independent activation pool in the neural plate. We utilized only the cFGFR2
construct because FGFR2 is more likely to be the endog-of FGF signaling (Neilson and Friesel, 1995, 1996). Over-
expression of either receptor completely blocked ac- enous signaling molecule through which eye field devel-
opment is affected. It is expressed in bilateral patchescess of D1.1.1 descendants to the retina; no embryo
contained labeled cells in the retina (cFGFR1, n  40; in the future dorso-anterior regions in the gastrula and
in the ectoderm surrounding the anterior neural plate,cFGFR2, n  72, Figure 1D). The majority of embryos
had smaller retinas on the injected side (Figures 1D and whereas FGFR1 is expressed more broadly in the gas-
trula, predominately in paraxial mesoderm (Golub et al.,1E), consistent with a subset of retinal progenitors being
absent on the injected side. Conversely, the average 2000). The expression of two eye field-specific genes
was repressed (Figure 1G; rx1 absent 69.2%, reducedretinal volume in embryos expressing a truncated FGF
receptor that inhibits FGF signaling (XFD; Amaya et al., 30.8%, n  26; pax6 absent 92.6%, reduced 7.4%, n 
27). To determine whether retinal development was sim-1991) was 11% larger than controls (p  0.05; Figure
1E). A more dramatic effect was observed when XFD ply delayed, the expression of Xath5, a marker for differ-
entiating retinoblasts (Kanekar et al., 1997), was moni-was expressed in a blastomere that gives rise to moder-
ate amounts of the retina (D1.2.1). The percentage of tored in tadpoles; it was absent (66.7%) or reduced
(33.3%; n  15) in cFGFR2-injected embryos (data notembryos that contained retinal progeny increased from
79% in controls (n  17) to 91% (n  55), and the size shown). Therefore, activation of the FGF pathway in the
major retina-producing lineage repressed retinal fateof the D1.2.1 contribution to the retina increased from
12%–25% in controls to 40%–60% in XFD-expressing beginning at least at eye field formation. Conversely,
repressing the FGF pathway via XFD expression moder-embryos (p  0.05). Thus, changes in FGF signaling
within dorsal animal lineages alter the size of the pool ately increased the size of the eye field (Figure 1H;
38.1%, n  42) and caused the XFD-expressing cells toof embryonic cells that contribute to the retina.
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be distributed more extensively through the eye field posterior neural fates (Munoz-Sanjuan and H-Brivanlou,
2001). However, cell fate analyses showed that cFGFR2(Figure 1H; 52%).
expression did not drive the D1.1.1 clone out of the
head, nor increase its size in posterior CNS. There alsoActivated FGFR2 Signaling Causes Cells
were no observable changes in the expression of severalto Adopt Ventral Neural Fates
genes with distinct anterior-to-posterior expression do-Even though the eye field and subsequently the retinas
mains (otx2, en2, krox20, hoxB9; supplemental data).were smaller in embryos expressing cFGFR2, a com-
Therefore activating the FGF pathway in the major retinalplete fate map analysis showed that FGFR2 activation
progenitor transformed retinal fates to ventral neuraldid not reduce the overall size of the D1.1.1 clone in the
fates via a pathway independent of hedgehog signaling,head (data not shown), suggesting that the progeny
mesoderm induction, or posteriorization of CNS fates.destined for the retina did not die but adopted other
fates. Consistent with this analysis, the neural tube was
Gastrulation Movements Are Abnormallarger on the injected side in 85% of the embryos (n 
in cFGFR2-Injected Embryos72; Figures 2A and 2B), and the width of the neural plate
Since the cFGFR2 phenotype is notable at neural platewas increased by 36% (n  21; p  0.001; Figure 2C).
stages and is not affected by signals that alter neuralIn many embryos, neural hypertrophy was more pro-
plate patterning, we analyzed clones at gastrulationnounced ventrally, suggesting that retinal fates were
stages. At stage 10, all control D1.1.1 clones weretransformed to ventral neural fates. Several observations
broadly dispersed from the animal pole to the blastoporeconfirm this. At neural plate stages, cFGFR2-expressing
lip, whereas in 27% of cFGFR2-injected animals (n cells were clustered at the midline, whereas in controls,
11), the clones were more confined toward the midlinecells were dispersed laterally (Figures 2D and 2E). At
(data not shown). At stage 12, all control clones (n tadpole stages, there were large coherent masses of
18) were broadly dispersed across the dorsal animalmedially located cFGFR2-expressing cells abutting the
quadrant (Figure 3A), whereas those expressing cFGFR2affected retina (Figures 1D and 2F), the majority of which
were more tightly confined to the midline (91.7%, n expressed the neural marker HNK-1 (Figure 2F). These
24; Figure 3B). In contrast, those expressing XFD alsocells were not displaced retinal progenitors, as none
were all fully dispersed (n  24; Figure 3C). At stage 14,expressed rx1 or Xath5 (data not shown). Instead, three
control D1.1.1 clones were broadly dispersed acrossventral forebrain fates were expanded. The expression
the anterior neural plate (92.3%, n  26; Figure 3D),domain of pax2, a marker for the optic stalk portion of
whereas those in cFGFR2-expressing embryos werethe ventral forebrain, was expanded at neural plate and
more closely confined near the midline (89.9%, n  27;tadpole stages (68%; n  22; Figures 2G and 2H). The
Figure 3E), presaging the ventral neural tube hypertro-number of dopamine neurons in the ventral hypothala-
phy and midline clusters of cFGFR2-expressing cellsmus was increased (n  15; p  0.001, Figure 2I), and
(Figure 2). Having established that D1.1.1 clones ex-the expression domain of Nkx2.4, a ventral forebrain
pressing XFD were dispersed (Figures 1H and 2C), wemarker (Small et al., 2000), was significantly larger
examined the clone of a blastomere that contributes
(ventral/dorsal ratio  1.39  0.07 versus 0.89  0.02
only moderately to the retina (D1.2.1). Normally, D1.2.1
in controls; p  0.0001; Figure 2J). Therefore, there
progeny populate the lateral border of the eye field (Fig-
is a compensatory increase in ventral neural fates ure 3F). Expression of XFD caused D1.2.1 progeny to
when retinal fates are repressed in cFGFR2-expressing populate the eye field at higher frequencies (91%, n 
lineages. 72) than controls (72%, n  29), and greater numbers
There are three known functions of FGF signaling that of cells were dispersed within the eye field (Figure 3G).
might cause these fate changes. First, interactions be- Thus, enhanced FGF signaling repressed the dispersal
tween the FGF and the Shh pathways are important in of cells in the anterior ectoderm, whereas reduced FGF
forebrain and retinal patterning (Macdonald et al., 1995; signaling enhanced it.
Ohkubo et al., 2002). However, Shh expression was not Since FGF signaling can affect cell movements and
altered in cFGFR2-injected embryos, nor did increased morphogenesis (Ornitz and Itoh, 2001), cFGFR2 repres-
hedgehog expression alter retinal clones (data not sion of cell dispersal during gastrulation suggests that
shown). Second, early FGF signaling promotes meso- this pathway may inhibit the movements of retinal pro-
derm formation (Slack et al., 1987; Amaya et al., 1991). genitors into the eye field. If true, then coexpression of
Although the notochord histologically appeared en- transcription factors previously demonstrated to en-
larged or duplicated in many embryos (Table 1), neither hance cell movements (Kenyon et al., 2001) should res-
chordin nor Xbra1 expression was changed in either cue the cFGFR2 phenotype. Coexpression of otx2, pax6,
whole embryos or animal cap explants in which cFGFR2 or rx1 with cFGFR2 in the D1.1.1 lineage each rescued
was expressed (see supplemental data at http://www. the retinal effects of cFGFR2 expression (Figure 3H)
developmentalcell.com/cgi/content/full/6/1/55/DC1), in proportions equivalent to their frequency to induce
nor was somite size or number changed. The minimal retinal fates. fh4 did not rescue the phenotype, consis-
effect on mesoderm formation is consistent with previ- tent with its inability to cause cell movements when
ous reports that 32-cell injections minimize exogenous ectopically expressed (Kenyon et al., 2001).
FGF effects on mesoderm induction (Moore and Moody, Although otx2, pax6, and rx1 each restored the D1.1.1
1999), and that cFGFR1 has more potent effects than clone to the retina, these genes were less successful at
cFGFR2 on mesoderm induction (Neilson and Friesel, rescuing the other components of the cFGFR2 pheno-
type (Table 1). cFGFR2/pax6-injected embryos showed1996). Third, FGF signaling is involved in establishing
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Figure 2. Activation of FGFR2 Signaling Increases the Size of the Neural Tube and Changes Retinal Fates to Ventral Neural Fates
(A and B) Neural tube is thicker on the cFGFR2-injected side (*). os, expanded optic stalk.
(C) White lines indicate extent of sox3 expression on control (right) and cFGFR2-injected (*) sides of neural plate.
(D) D1.1.1 clone (green) in stage 14 forebrain region of control. Arrow denotes midline.
(E) D1.1.1 clone (green) in the same region of cFGFR2-injected embryo.
(F) Expanded neural tube on cFGFR2-injected side (*). Brown stain indicates HNK-1 expression.
(G) Expression of cFGFR2 in D1.1.1 clone (red) expands pax2 expression on the injected side (*) of neural plate.
(H) Expression of cFGFR2 in D1.1.1 expands forebrain pax2 expression (white bracket) on the injected side (inj) of tail bud embryos. un, un-
injected.
(I) Number of dopamine cells in the hypothalamus of cFGFR2-injected embryos. *, p  0.001.
(J) The lengths of dorsal (black line) and ventral (Nkx2.4; white line) forebrain domains in cFGFR2-injected and wild-type (wt) embryos.
the greatest extent of rescue, but only rarely (12.5%) ephrinB1 Can Completely Rescue
the cFGFR Phenotypewas the cFGFR2 phenotype completely rescued. Increas-
ing the pax6 mRNA dosage from 50 to 100 pg increased The regulation of retinal progenitor movements during
gastrulation and eye field formation likely involves thethe frequency of retinal clone rescue but still did not
rescue the nonretinal phenotypes (Table 1). These data temporal and spatial coordination of cell adhesive
events. FGFs are among several proteins that are impli-indicate that another molecular component is involved
in the cFGFR2 inhibition of retinal fate acquisition. cated in regulating such events, and FGF receptors can
Retinogenesis and FGFR-ephrinB1 Signaling
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Table 1. Ability of Factors to Rescue cFGFR2 Phenotypes
Percentage of Embryos Exhibiting Phenotype
ephrinB1 ephrinB1
cFGFR2 otx2 rx1 pax6 (n  21) (n  8)
Phenotype (n  48) (n  24) (n  29) (n  48) 100 pg 500 pg
No retinal clone 100 70 45 33 14 0
Smaller retina 100 100 75 72 11 0
Neural tube hypertrophy 85 86 81 56 36 0
Ectopic cell masses 100 100 88 72 22 0
Expanded notochord 80 72 75 75 5 0
interact with several cell adhesion molecules that regu- ephrinB1 (Jones et al., 1997), and a receptor for ephrinB1
(EphB2; Tanaka et al., 1998) are all expressed duringlate cell-to-cell interactions, including transmembrane
(Type B) ephrins (Doherty et al., 1996; Holder and Klein, gastrulation and neural plate stages in the anterior neu-
ral plate region. A careful comparison of the expression1999; Palmer and Klein, 2003). The FGF receptor can
associate with and induce the phosphorylation of domains of pax6, ephrinB1, and fgfr2 demonstrates that
(1) strong ephrinB1 expression overlaps with that ofephrinB1 within the same cell, resulting in effects on
cell adhesion when ectopically expressed in Xenopus pax6 (and rx1, not shown) along the anterior margin of
the eye field, and lower levels of ephrinB1 are expressed(Chong et al., 2000). Furthermore, components of both
the FGF and ephrin/Eph signaling pathways are ex- within the rest of the eye field; (2) ephrinB1 and fgfr2
expression overlap along an anterolateral crescent thatpressed in coincident temporal and spatial patterns that
would allow them to interact and regulate retinal progen- borders the eye field; and (3) fgfr2 expression does not
overlap with that of pax6 (or rx1, not shown) (Figure 4A).itor movements. FGFR1, 2, and 4 (Golub et al., 2000),
Figure 3. Gastrulation Movements Are Al-
tered in Clones with Enhanced or Repressed
FGF Signaling
(A) Animal pole at stage 12 showing control
D1.1.1 clone (red).
(B) Stage 12 embryos expressing cFGFR2 in
D1.1.1 clone (red).
(C) Stage 12 embryo expressing XFD in D1.1.1
clone (red).
(D) Anterior view at stage 14 showing control
D1.1.1 clone (red).
(E) Stage 14 embryos expressing cFGFR2 in
D1.1.1 clone (red).
(F) Control stage 15 embryo showing control
D1.2.1 clone (bright blue) at lateral edge of
eye field (rx1 expression).
(G) Embryos expressing XFD in D1.2.1 clones
that extensively populate the eye field.
(H) Percentage of embryos with D1.1.1 prog-
eny in retina after coexpression of cFGFR2
and anterior neural plate transcription fac-
tors. *, p  0.05.
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Figure 4. ephrinB1 Rescues the cFGFR Retinal Phenotype
(A) Anterior views at stage 16 show control expression domains of pax6, ephrinB1, and fgfr2. Asterisks indicate the anterior tip of the neural
groove, allowing an anatomical comparison of the domains.
(B) Blastomeres that contribute large numbers (D1.1.1, top) or very small numbers (V1.2.1, bottom) of cells to the retina were injected with
-gal mRNA, and the location of anterior descendants (red) compared to the expression domains of pax6, ephrinB1, and fgfr2 (blue patches,
arrows). Top, frontal views; bottom, pax6 is frontal; ephrinB1 and fgfr2 are side views.
(C) Animal poles at stage 12 showing D1.1.1 clone (red) coexpressing cFGFR2 and ephrinB1.
(D) Anterior view at stage 16 showing D1.1.1 clone (red) coexpressing cFGFR2 and ephrinB1.
(E) Coexpression of ephrinB1 rescues the cFGFR2 repression of D1.1.1 contribution to the retina in a dose-dependent manner. ephrinB1-
60AA does not rescue.
(F) Coexpression of ephrinB1 with cFGFR2 allows D1.1.1 progeny (green) to populate the retina.
Comparison of the location of blastomere clones that borders of the eye field may regulate the movements of
cells into the eye field.have differential contributions to the retina further sug-
gest that ephrinB1 and FGFR2 might regulate cell move- To test this, ephrinB1 and cFGFR2 mRNAs were co-
injected into D1.1.1. At stage 12, the normal gastrulationments in the vicinity of the eye field. Clones that contrib-
ute to 50% of the retina (D1.1.1) are dispersed across pattern was restored; ephrinB1/cFGFR2 clones were
broadly dispersed anteriorly (Figure 4C; 67.9%, n  28),the pax6-expressing eye field (100%, n  14) and are
confined within anterior and lateral borders delineated and in 21.4% several cells were scattered long distances
from the main clone, indicating increased cell move-by high ephrinB1 (95.5%, n  22) and fgfr2 (94.4%,
n  18) expression (Figure 4B). In contrast, clones that ment. By stage 15, the normal phenotype of full anterior
dispersal and population of a restored eye field wascontribute to 1% of the retina (V1.2.1) populate the
lateral boundary of the pax6 domain (100%, n  5), observed (Figure 4D; 100%, n  15). Coexpression of
ephrinB1 rescued the cFGFR2 repression of D1.1.1 pop-coinciding with the anterolateral patch that expresses
high levels of ephrinB1 (92.8%, n  28) and fgfr2 (90%, ulation of the retina in a dose-dependent manner (Fig-
ures 4E and 4F). The proportion of the retina derivedn  20) (Figure 4B). These patterns suggest that the
expression of these two signaling molecules along the from the cFGFR2/ephrinB1-expressing clone increased
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with larger ephrinB1 mRNA doses, such that all embryos dispersed (90.5%, n  21), and the majority of clones
receiving 500 pg had retinal clones equivalent in size to spread across the entire animal hemisphere (76.2%, Fig-
controls. Retinal size increased in a dose-dependent ure 5G). The ability of ectopic ephrinB1 to change the
manner: 50 pg of ephrinB1 mRNA restored retinas to morphogenetic movements of ventral clones was de-
wild-type (6.2  106 	m3), and larger doses caused pendent upon reverse signaling since clones expressing
significantly larger retinas (250 pg: 6.9  106 	m3; 500 the ephrinB1(–60AA) mutant were mostly coherent (71.4%,
pg: 7.5 106 	m3; p 0.05). Thus, increased ephrinB1 n  21) and positioned to one side of the animal pole
signaling enabled more cells to adopt retinal fates. The (100%, Figure 5H). However, V1.1.1 clones expressing
rescue was dependent upon the ability of ephrinB1 to XFD resembled the ephrinB1(Y305, Y310) phenotypes
reverse signal since a mutant ephrinB1 that lacks its (51.2%, n  41; Figure 5I top); in the remainder, several
intracellular signaling domain (ephrinB1–60AA; Chong cells were dispersed into the dorsal midline (Figure 5I,
et al., 2000) did not rescue the cFGFR phenotype (Figure bottom). That these gastrulation movement changes re-
4E). Increased ephrinB1 signaling also rescued the non- sulted in an increased population of the eye field was
retinal phenotypes of cFGFR2 (Table 1). A 100 pg confirmed by examining XFD-expressing V1.1.1 clones
ephrinB1 dose significantly reduced the frequency of at neural plate stages. In controls, V1.1.1 clones lay
neural tube hypertrophy, ectopic masses, and expanded ventral to the eye field (100%, n45; Figure 5J), whereas
notochords, and 500 pg eliminated all cFGFR2 pheno- in XFD-expressing embryos, these cells were often
types. within the eye field (34%, n  97; Figure 5K). Thus,
If an ephrinB1-FGFR interaction were responsible for both enhanced reverse ephrinB1 signaling and reduced
controlling the cell movements that regulate which cells FGFR signaling caused greater cellular dispersal and
gain access to the eye field, then ectopic ventral expres- movement into the retinal region of the animal hemi-
sion of ephrinB1 should cause epidermal progenitors to sphere.
move into the anterior neural plate and adopt a retinal
fate. To test this, wild-type ephrinB1 was expressed in a ephrinB1 Is Necessary for Retinal Progenitors
blastomere that normally never contributes to the retina to Move into the Eye Field
(V1.1.1); 42% of embryos contained V1.1.1 progeny in A knockdown of ephrinB1 expression was performed
the retina (Figure 5A; n  17). Since wild-type ephrinB1 using antisense morpholino oligonucleotides (MO) to
may be subject to signaling modification by endogenous determine whether this protein is necessary for retinal
FGFR signaling, we also expressed a mutant form progenitors to move into the eye field. To test the ability
[ephrinB1(Y305, Y310)] in which the two tyrosines are of the ephrinB1-MO to block ephrinB1 protein accumu-
altered to phenylalanines; this prevents ephrinB1 asso- lation, lysates from embryos injected with ephrinB1
ciation with and modulation by FGFR but does not alter mRNA alone or with MOs were analyzed on Western
cell de-adhesion (Chong et al., 2000). The expression blots. ephrinB1-MO completely blocked the expression
of ephrinB1(Y305, Y310) in blastomeres that normally of ephrinB1 protein (Figure 6A), whereas neither an in-
never contribute to the retina (V1.1.1, V1.1.2; Figure 5C) verted ephrinB1-MO nor a standard control MO did.
caused their progeny to populate the retina at significant The translation of a 5
 truncated ephrinB1 (ephrinUTR)
frequencies (Figures 5A and 5D). In the case of V1.1.1, mRNA was not blocked by the ephrinB1-MO, and thus
ephrinB1(Y305, Y310) caused a higher percentage of was used for rescue experiments. Translation of ephrinB3
embryos to contain retinal clones compared to wild- mRNA (Helbling et al., 1999), which encodes a related
type ephrinB1. Reverse signaling is required for these ligand recognized by the same antibody, was not blocked
effects, since the ephrinB1(–60AA) mutant did not cause
by the ephrinB1-MO, indicating that ephrinB1-MO is
changes in fate (Figure 5A). Consistent with these data,
specific for this family member.
reduction of FGF signaling via XFD expression also
Injection of ephrinB1-MO into D1.1.1 prevented itscaused the V1.1.1 clone to populate the retina (n  46,
progeny from populating the retina in a dose-dependentFigures 5A and 5E). Expression of ephrinB1(Y305, Y310)
manner, whereas the inverted ephrinB1-MO did not (Fig-in a blastomere that normally makes a minor contribution
ures 6B–6D). In the embryos that did contain D1.1.1to the retina (V1.2.1) was sufficient to nearly double the
progeny in the retina, the retinal clones were alwayspercentage of embryos containing retinal clones (Figure
significantly smaller (1%–10%; Figure 6B). Higher doses5A), and increased the retinal cell contribution from1%
phenocopied other aspects of the cFGFR2 phenotypein controls to 12%–50% (Figure 5B). Likewise, expres-
including smaller retinas, larger neural tubes, and largesion of XFD increased the percentage of embryos con-
cell masses adjacent to the retina (Figure 6C). Coexpres-taining V1.2.1-derived retinal clones (n  81, Figure 5A)
sion of ephrinB1UTR mRNA with the ephrinB1-MO fullyand the size of the V1.2.1 retinal clone (1% in controls;
restored the D1.1.1 clone to the retina (Figure 6D). These25%–50% in XFD). Together these results suggest that
data demonstrate that the effects were specific toan interaction with FGFR normally inhibits the function
ephrinB1 and that ephrinB1 signaling is necessary forof ephrinB1 in promoting the recruitment of cells into
appropriate movement of anterior ectodermal cells tothe retina.
acquire a retinal fate.To determine whether these transformations from epi-
dermal to retinal fates correlated with cell movement
Is the Rescue of Retinal Fate by Coexpressionchanges, gastrulation movements were monitored. At
of ephrinB1 and FGFR2 Mediated bystage 12, control V1.1.1 clones were coherent (100%,
Transcriptional Regulation?n  21) and most had withdrawn from the dorsal side
The results presented above suggest that either direct orof the animal pole (66.7%, Figure 5F). In contrast, V1.1.1
clones expressing ephrinB1(Y305, Y310) were widely indirect signaling between FGFR2 and ephrinB1 affects
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Figure 5. ephrinB1 Causes Epidermal Pro-
genitors to Move into the Eye Field and Popu-
late the Retina
(A) Percentage of embryos in which progeny
from ventral blastomeres populated the ret-
ina. GFP indicates control embryos.
(B) Expression of ephrinB1(Y305, Y310) in
V1.2.1 progeny (green) in retina.
(C) Progeny of V1.1.2 (green) do not normally
populate the retina.
(D) Expression of ephrinB1(Y305, Y310) in
V1.1.2 progeny (green) in retina.
(E) Expression of XFD in V1.1.1 progeny
(green) in retina.
(F) Stage 12 embryos showing control V1.1.1
lineage (red). Asterisk indicates the animal
pole. Dorsal is to the top.
(G) Stage 12 embryos expressing ephrinB1
(Y305, Y310) in the V1.1.1 lineage.
(H) Stage 12 embryos expressing ephrinB1
(–60AA) in the V1.1.1 lineage.
(I) Stage 12 embryos expressing XFD in the
V1.1.1 lineage.
(J) Anterior view of stage 15 control V1.1.1
lineage (bright blue) ventral to eye field (rx1).
(K) Stage 15 embryos showing XFD-express-
ing V1.1.1 cells (bright blue) within eye field.
cell movement. Alternatively, FGFR signaling could lead ephrinB1-MO-injected embryos fully restored the D1.1.1
clone to the retina (95.5%, n 22; Figure 6G). However,to alterations in transcription. It is possible that cFGFR2
downregulates retinal fate by repression of pax6 and/or ephrinB1-injected embryos failed to display any ectopic
or expanded expression of pax6 (n  38; Figure 6H) orrx1 transcription (Figure 1G) rather than of cell move-
ment. However, in animal cap explants in which cell rx1 (n  40), indicating that ephrinB1 does not directly
regulate eye field genes but does effectively signalmovement effects on cell fate are minimal, expression of
cFGFR2 in noggin-injected animal caps did not repress changes in cell movement.
either pax6 or rx1 expression (supplemental data). Simi-
larly, expression of cFGFR2 did not repress ephrinB1 Discussion
expression (supplemental data), consistent with a previ-
ous report (Jones et al., 1997). However, eye field tran- There are three major morphogenetic movements that
bring embryonic cells into the correct position to formscription factors likely act downstream of ephrinB1 to
promote a retinal fate. First, knockdown of ephrinB1 the retina. During gastrulation, epiboly movements posi-
tion dorsal ectoderm in register with signaling centersexpression repressed both rx1 (88.6%, n 35) and pax6
(84%, n  25; Figure 6E) expression, whereas neither that induce anterior neural ectoderm. During formation
of the neural plate, forebrain and eye field cells disperserx1 (1.9%, n  108) nor pax6 (0%, n  71; Figure 6F)
mRNA injection caused ectopic or expanded expression and intermix with adjacent lineages (Wetts and Fraser,
1988; Bauer et al., 1994). Finally, cells of the single eyeof ephrinB1. Second, coexpression of pax6 mRNA in
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Figure 6. ephrinB1 Is Necessary for Retinal
Progenitors to Move into the Eye Field
(A) Embryos were injected with ephrinB1
mRNA alone, or plus an ephrinB1 morpholino
(MO), inverted ephrinB1-MO (invert ctl), or
standard control MO (std ctl), and analyzed
by Western blot. The ephrinB1-MO does not
block the translation of a 5
 truncated
ephrinB1 (ephrinB1UTR) or of ephrinB3,
which is recognized by the same antibody.
(B and C) ephrinB1-MO injected into D1.1.1
(green) represses population of retina.
(D) Percentage of embryos with D1.1.1 clones
in retina. ephrinB1-MO caused a dose-depen-
dent reduction (p  0.05 at all doses).
(E) ephrinB1-MO injection into D1.1.1 re-
presses pax6 expression (arrow).
(F) Ectopic expression of pax6 (red) does not
induce ectopic ephrinB1 (blue).
(G) Expression of pax6 in an ephrinB1-MO-
injected embryo restores D1.1.1 clone (green)
to retina.
(H) Ectopic expression of ephrinB1 (red) does
not induce ectopic pax6 expression (blue).
field are displaced or move laterally to form the left candidate for regulating retinogenic cell movements.
Our data show that FGFR2 signaling represses cell dis-and right eye primordia (Varga et al., 1999). Very little is
known about the molecular regulation of these critical persal at the midline of the neural plate, whereas
blocking this function increases cellular dispersal intoearly steps in retinogenesis. Although otx2, rx1, and
pax6 have been implicated in regulating retinogenic cell the eye field. Another candidate signaling pathway for
regulating retinogenic cell movements are ephrins andmovements (Chuang and Raymond, 2001; Kenyon et al.,
2001), the upstream signaling factors have not been their tyrosine kinase receptors (Ephs), which have im-
portant roles in several developmental processes involv-delineated. Since FGF signaling is involved in several
morphogenetic movements (Rossant et al., 1997; Sun ing cell migration and morphogenetic movements
(Jones et al., 1998; Holder and Klein, 1999; Xu et al.,et al., 1999; Wacker et al., 1998) and cell adhesive inter-
actions (Kinoshita et al., 1993), this pathway is an ideal 1999; Wilkinson, 2001; Williams et al., 2003). We found
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that ephrinB1 is normally necessary for retinogenic cells et al., 2000; PDGF, Bruckner et al., 1997), both of which
to acquire a retinal fate, as evidenced by repression lead to the recruitment of signaling effectors to the cyto-
of endogenous ephrinB1 translation by ephrinB1-MO. plasmic tail (Kullander and Klein, 2002). Reverse signal-
Moreover, ephrinB1 signaling is sufficient to rescue the ing is important for many morphogenetic events (Adams
inhibition of retinal fate caused by activated FGFR2, and et al., 2001; Xu et al., 1999; Huynh-Do et al., 2002), and
that repression of FGFR signaling by XFD expression herein we demonstrate that the ability of ephrinB1 to
phenocopies the ephrinB1 effects. alter the gastrulation movements of retinogenic cells,
The downstream events of ephrin signaling are com- rescue the cFGFR2 effect, or cause ventral epidermal
plex and not yet fully understood. However, it has been cells to populate the eye field is dependent upon reverse
demonstrated that ephrinB1 can be modulated by FGFR signaling through its cytoplasmic domain. These results
within the same cell. Chong et al. (2000) showed in Xeno- suggest that FGFR signaling is involved in regulating the
pus that the FGF receptor associates with and induces ephrinB1 retinogenic effects because FGFR has been
the phosphorylation of ephrinB1 both in vitro and in vivo. shown to interact with ephrinB1 within the same cell in
Based on this known interaction, we propose that during a manner dependent upon specific tyrosine residues
normal development cells are recruited to the eye field within the deleted domain (Chong et al., 2000). More-
by activation of the ephrinB1 signaling pathway, which over, an ephrinB1 protein harboring substitutions for
allows them to disperse. An activated FGFR is likely tyrosines 305 and 310 is able to effectively drive ventral
to influence ephrinB1 function along the anterolateral blastomeres toward a retinal fate at higher percentages
borders of the anterior neural plate, based on the endog- than does the wild-type ephrinB1 protein that is subject
enous expression domains of fgfr2 and ephrinB1, sup- to FGFR interactions. These tyrosine residues are critical
pressing this cell movement and thereby repressing a for FGFR-mediated rescue of ephrinB1-induced effects
retinal fate. This hypothesis is supported by the observa- on cell adhesion (Chong et al., 2000) and are the in vivo
tions that (1) retinogenic clones disperse across the phosphorylation sites in embryonic chick retina (Kalo
eye field domains that express pax6, rx1, and moderate et al., 2001). Thus, although we do not know whether
ephrinB1; (2) clones that barely contribute to the retina ephrinB1 forward signaling is involved in promoting reti-
do not extend beyond a patch that coexpresses high nogenic cell movements, reverse signaling is critical to
levels of both ephrinB1 and fgfr2; (3) ephrinB1 expres- promote this important step in retinal development.
sion counteracts the retina-suppressing effects of acti-
vated FGFR2, restores the dispersal of FGFR2-express-
Experimental Proceduresing cells in the anterior neural plate, and causes ventral
epidermal progenitors to disperse more than normal
Blastomere Injectionsand enter the eye field. None of these functional effects
Fertilized Xenopus laevis eggs were obtained by standard methods
occurred with an ephrinB1(–60AA) construct lacking the (Moody, 1999) and injected with the following mRNAs: -gal (100
intracellular domain that is modulated by FGFR; and (4) pg), gfp (200 pg), bhh (100 pg; Ekker et al., 1995), cFGFR1, cFGFR2
the repression of FGFR signaling by XFD expression (10–100 pg; Neilson and Friesel, 1995, 1996), otx2 (50 pg; Blitz and
Cho, 1995), pax6 (50 pg; Hirsch and Harris, 1997), rx1 (50 pg; Mathersphenocopied the ephrinB1 effects. These results indi-
et al., 1997), fh4 (50 pg; Dirksen and Jamrich, 1995), ephrinB1 (50–cate that ephrinB1 is involved in promoting morphoge-
500 pg; Jones et al., 1997), ephrinB1Y305Y310 (100 pg), ephrinB1-netic movements that are necessary to establish the eye
60AA (100–250 pg; Chong et al., 2000), ephrinB1(UTR) (100–250
field and express a retinal fate. pg), and XFD (250 pg; Amaya et al., 1991). An ephrinB1 morpholino
Type B ephrins can signal in two directions, forward (MO), designed to 12 bases of the 5
 UTR and 13 bases of the ORF,
and reverse (Wilkinson, 2001; Palmer and Klein, 2003). its inverted control, and a standard control were synthesized (Gene
Forward signaling occurs when the ligand binds to an Tools). For rescue of MO effects, mRNA was synthesized from
ephrinB1UTR, which lacks the 5
 UTR and contains four pointEph tyrosine kinase receptor on an adjacent cell and
mutations in wobble codons.activates a signaling cascade within that cell (Gale et
al., 1996). ephrinB1/Eph signaling is involved in several
morphogenetic events, including dorsal axis formation Cell Fate Analysis
(Tanaka et al., 1998), skeletogenesis (Compagni et al., Blastomeres were injected with a mixture of gfp and test mRNAs.
2003), and proper cell positioning in the intestinal epithe- Tissue sections of stage 37/38 embryos were analyzed for the pres-
ence of GFP-labeled cells, and their distribution compared to estab-lium (Batlle et al., 2002). However, it is not known
lished lineage maps (Moody, 1987) and to gfp-injected controls. Thewhether ephrinB1 binding to a cognate Eph receptor is
frequencies that embryos contained labeled cells in the retina inrequired to promote a retinogenic fate. Targeted disrup-
experimental and control groups were compared using the z-testtion of three Eph receptors that can bind ephrinB1 have
of proportions. Retinal volumes were calculated from serial tissuenot been reported to affect retinogenic cell fate deci-
sections as described (Moore and Moody, 1999) and compared by
sions (Henkemeyer et al., 1996; Orioli et al., 1996; Wil- the t test.
liams et al., 2003). Nonetheless, our results strongly im-
plicate signaling from the intracellular domain of ephrinB1
Animal Cap Assaysas critical to this process.
Both blastomeres of 2-cell embryos were injected with mRNA, andEphrins can transduce signals via their cytoplasmic
at stage 8/9 animal cap explants were isolated and cultured. Atdomain within their host cells, referred to as “reverse
neural plate stages, explants were processed for either in situ hy-signaling.” The cytoplasmic tail of ephrinB1 becomes
bridization (below) or PCR. RNA was isolated (Purescript, Gentra),
tyrosine phosphorylated, either upon its binding to a reverse transcribed (Superscript First Strand, InVitrogen) and ampli-
cognate receptor in an adjacent cell (Holland et al., 1996; fied by PCR, using primer sequences and conditions for Xbra and
Bruckner et al., 1997) or by the activation of other signal- EF1 (Hemmati-Brivanlou and Melton, 1994), ephrinB1 (Jones et al.,
1997), and rx1 and pax6 (Onuma et al., 2002).ing cascades within the same cell (FGF or FGFR, Chong
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Whole-Mount In Situ Hybridization Bruckner, K., Pasquale, E.B., and Klein, R. (1997). Tyrosine phos-
phorylation of transmembrane ligands for Eph receptors. ScienceEmbryos were injected with a mixture of -gal and test mRNA,
assayed for -Galactosidase activity, and processed for whole- 275, 1640–1643.
mount in situ hybridization using standard methods (Sive et al., Cho, K.W., Morita, E.A., Wright, C.V., and De Robertis, E.M. (1991).
2000) and the following probes: Xbra (Smith et al., 1991), chordin Overexpression of a homeodomain protein confers axis-forming ac-
(Sasai et al., 1994), engrailed 2 (Hemmati-Brivanlou et al., 1991), tivity to uncommitted Xenopus embryonic cells. Cell 65, 55–64.
ephrinB1 (Jones et al., 1997), fgfr2 (Friesel and Brown, 1992; Golub
Chong, L.D., Park, E.K., Latimer, E., Friesel, R., and Daar, I.O. (2000).et al., 2000), hoxB9 (Cho et al., 1991), Krox20 (Hemmati-Brivanlou
Fibroblast growth factor receptor-mediated rescue of x-Ephrin B1-et al., 1991), Nkx2.4 (Small et al., 2000), pax2 (Heller and Brandli,
induced cell dissociation in Xenopus embryos. Mol. Cell. Biol. 20,1999), pax6 (Hirsch and Harris, 1997), rx1 (Mathers et al., 1997), shh
724–734.(gift of R. Moon), sox3 (gift of R. Grainger), and Xath5 (Kanekar et
Chow, R.L., Altmann, C.R., Lang, R.A., and Hemmati-Brivanlou, A.al., 1997). To determine whether the neural plate was expanded, the
(1999). Pax6 induces ectopic eyes in a vertebrate. Developmentwidth of sox3 expression on both cFGFR2-injected and uninjected
126, 4213–4222.sides were measured with an eyepiece micrometer. The mean percent
difference between sides was compared to similar measurements from Compagni, A., Logan, M., Klein, R., and Adams, R.H. (2003). Control
control embryos by the t test. To determine whether ventral forebrain of skeletal patterning by EphrinB1-EphB interactions. Dev. Cell 5,
was expanded, the lengths of the Nkx2.4 and Nkx2.4 domains in 217–230.
transverse sections were similarly measured and compared.
Chuang, J.C., and Raymond, P.A. (2001). Zebrafish genes rx1 and
rx2 help define the region of forebrain that gives rise to retina. Dev.
Biol. 231, 13–30.
Immunohistochemistry
Dirksen, M.L., and Jamrich, M. (1995). Differential expression of forkEmbryos injected with cFGFR2 mRNA were raised to stages 37/38
head genes during early Xenopus and zebrafish development. Dev.for detection of neural-specific HNK-1 glycoprotein (ATCC) or 12/
Genet. 17, 107–116.101 somitic muscle antigen (Developmental Hybridoma Bank), and
to stage 44 for detection of tyrosine hydroxylase in dopamine cells Doherty, P., Smith, P., and Walsh, F.S. (1996). Shared cell adhesion
(ImmunoStar), using standard immunohistochemistry protocols molecule (CAM) homology domains point to CAMs signalling via
(Huang and Moody, 1992). Nuclei were stained with Hoechst dye FGF receptors. Perspect. Dev. Neurobiol. 4, 157–168.
and the number of immunopositive cells counted. Ekker, S.C., McGrew, L.L., Lai, C., Lee, J.J., von Kessler, D.P., Moon,
R.T., and Beachy, P.A. (1995). Distinct expression and shared activi-
ties of members of the hedgehog gene family of Xenopus laevis.
Western Blot Analysis
Development 121, 2337–2347.
Embryos were injected with ephrin mRNAs, embryonic lysates pre-
Friesel, R., and Dawid, I.B. (1991). cDNA cloning and developmentalpared, two embryo equivalents resolved by SDS-PAGE on 10% gels,
expression of fibroblast growth factor receptors from Xenopusand Western blots probed with an anti-Lerk2 C-terminal antibody
laevis. Mol. Cell. Biol. 11, 2481–2488.that recognizes both ephrinB1 and ephrinB3 proteins, as described
(Jones et al., 1998; Chong et al., 2000). Friesel, R., and Brown, S.A. (1992). Spatially restricted expression
of fibroblast growth factor receptor-2 during Xenopus development.
Development 116, 1051–1058.
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